10-K: Tredegar Corporation Reports Full Year 2023 Results, Navigates Market Headwinds and Strategic Shifts

Tredegar Corporation's 2023 results reflect a challenging year marked by decreased sales, a net loss, and strategic actions including the planned sale of its Flexible Packaging Films business.

Summary

• Tredegar Corporation reported a net loss of $105.9 million, or $3.10 per diluted share, for 2023, compared to a net income of $28.5 million, or $0.84 per diluted share, in 2022.
• Sales decreased by 24.9% to $704.8 million in 2023 from $938.6 million in 2022, with declines across all segments.
• Aluminum Extrusions net sales decreased by 25.6% due to lower volume and the pass-through of lower metal costs.
• PE Films net sales decreased by 21.3% primarily due to lower volume in Surface Protection.
• Flexible Packaging Films net sales decreased by 24.9% due to lower sales volume and margin pressures.
• The company experienced a pre-tax pension settlement loss of $92.3 million in 2023.
• A non-cash partial goodwill impairment of $34.9 million was recognized in 2023.
• Open orders in Aluminum Extrusions decreased by 65% to $48 million at the end of 2023 compared to $136 million at the end of 2022.
• The company entered into an agreement to sell its Flexible Packaging Films business to Oben Group, with completion contingent upon regulatory approvals.
• Tredegar transitioned to a $180 million asset-based revolving credit facility (ABL) in December 2023, which will reduce to $125 million upon the earlier of March 31, 2025 or the closing of the sale of Terphane.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to significant financial losses, declining sales, and strategic challenges. While there are some positive aspects, such as cost-cutting measures and the planned sale of Terphane, the overall tone is pessimistic from an investment perspective.

Positives

• PE Films saw an increase in gross profit margin due to higher overwrap films contribution margin, cost improvements and favorable LIFO inventory adjustments.
• The company completed the pension plan termination process, transferring the obligation to Massachusetts Mutual Life Insurance Company.
• The company believes it has adequate supply agreements for aluminum raw materials in 2024.
• The company believes there will be an adequate supply of polyethylene and polypropylene resins in the foreseeable future.
• The company believes there will be an adequate supply of polyester resins, PTA and MEG in the foreseeable future.

Negatives

• The company reported a significant net loss of $105.9 million for 2023.
• Sales across all segments declined substantially, with a 24.9% decrease in consolidated sales.
• Aluminum Extrusions experienced a significant drop in open orders, indicating weaker demand.
• The company incurred a $92.3 million pre-tax pension settlement loss.
• A $34.9 million non-cash goodwill impairment was recognized, primarily related to the Surface Protection business.
• The company is currently subject to a Cash Dominion Period under the ABL Facility, limiting financial flexibility.
• The ABL Facility borrowing availability will be reduced from $180 million to $125 million upon the earlier of March 31, 2025 or the date the company receives the proceeds from the sale of Terphane.

Risks

• The planned divestiture of Terphane is subject to closing conditions and regulatory approvals, which may not be met.
• The company's transition to the asset-based revolving credit facility (ABL) could be challenging, with potential impacts on financial flexibility.
• Macroeconomic factors, including inflation and high interest rates, could further adversely impact the company's businesses.
• The company's performance is influenced by volatile raw material and energy costs, which may not be fully offset by price increases.
• Disruptions at major manufacturing facilities could negatively impact financial results.
• Unfairly traded imports of aluminum extrusions could injure the domestic industry.
• PE Films is highly dependent on a few large customers, and the loss of one or more could have an adverse effect.
• Overcapacity in Latin American polyester film production could adversely impact Flexible Packaging Films.
• Uncertain economic conditions in Brazil could adversely impact Flexible Packaging Films.
• Cybersecurity attacks or other IT system failures could negatively affect the company's business.

Future Outlook

The company expects to realize after-tax cash proceeds of $85 million from the sale of Terphane, after deducting projected Brazil withholding taxes, escrow funds, U.S. capital gains taxes and transaction costs. The company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, and debt repayments for at least the next 12 months.

Management Comments

• The company continuously focuses on working capital management.
• The company believes that its Bonnell Aluminum, PE Films and Flexible Packaging Films manufacturing facilities have sufficient capacity to meet current production requirements.
• The company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, and debt repayments for at least the next 12 months.

Industry Context

The report highlights challenges in the building and construction and consumer electronics markets, which are cyclical and sensitive to economic conditions. The company is also facing increased competition from imports, particularly in the aluminum extrusions and flexible packaging films sectors. The planned sale of the Flexible Packaging Films business reflects a strategic shift in response to these market dynamics.

Comparison to Industry Standards

• The decrease in open orders for Aluminum Extrusions to $48 million, or 14 million pounds, at December 31, 2023, compared to $136 million, or 41 million pounds, at December 31, 2022, is below the quarterly range of 21 to 27 million pounds in 2019 before pandemic-related disruptions, indicating a significant downturn compared to pre-pandemic levels.
• The company's safety performance has continuously exceeded industry standards in its respective manufacturing sectors.
• The company's top four PE Films customers comprised 87% of its net sales in 2023, which is a high concentration compared to industry averages, indicating a significant reliance on a few key accounts.
• The company's gross profit margin of 11.2% in 2023 is lower than the 14.9% in 2022, indicating a decline in profitability compared to the previous year.
• The company's days sales outstanding (DSO) of 45.1 days in 2023 is lower than the 48.7 days in 2022, indicating an improvement in the collection of receivables.
• The company's days inventory outstanding (DIO) of 51.6 days in 2023 is lower than the 53.6 days in 2022, indicating an improvement in inventory management.
• The company's days payables outstanding (DPO) of 49.8 days in 2023 is lower than the 64.2 days in 2022, indicating a decrease in the time taken to pay suppliers.

Stakeholder Impact

• Shareholders will be negatively impacted by the net loss and declining stock price.
• Employees may be affected by restructuring and cost-cutting measures.
• Customers may experience changes in product availability and pricing.
• Suppliers may be affected by changes in the company's purchasing patterns.
• Creditors may be concerned about the company's financial performance and debt levels.

Next Steps

• The company will continue to work towards completing the sale of its Flexible Packaging Films business.
• The company will focus on managing its working capital and controlling costs.
• The company will continue to monitor the regulatory review process for the sale of Terphane.
• The company will continue to implement the new ERP/MES system for Aluminum Extrusions.

Key Dates

Keywords

aluminum extrusions, PE films, flexible packaging films, Terphane, asset-based lending, goodwill impairment, pension settlement, financial results, market conditions, strategic initiatives